Tai Yin Yang
Fortune : 47 981 $ au 31/05/2026
Fortune : 47 981 $ au 31/05/2026
Tai Yin Yang is currently an Independent Director at Kodiak Sciences, Inc. since 2019 and an Independent Non-Executive Director at Brii Biosciences Ltd. (China) since 2022.
Memberships include the American Chemical Society, National Academy of Engineering since 2022, American Association of Pharmaceutical Scientists, and Drug Information Association.
Former roles include Independent Director at Kronos Bio, Inc. from 2021 to 2025, Director-Analytical Chemistry at Syntex Corp., and EVP-Pharmaceutical Development & Manufacturing at Gilead Sciences, Inc. from 2015 to 2022.
Education includes a doctorate from the University of Southern California and an undergraduate degree from National Taiwan University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/09/2025 | 327 000 ( 0,04% ) | 47 981 $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KODIAK SCIENCES INC. | Directeur/Membre du Conseil | 17/12/2019 |
| BRII BIOSCIENCES LIMITED | Directeur/Membre du Conseil | 01/09/2022 |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Corporate Officer/Principal | - |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Corporate Officer/Principal | - |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Corporate Officer/Principal | - |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | 01/01/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| KRONOS BIO, INC. | Directeur/Membre du Conseil | 20/06/2025 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 18/07/2022 |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Commercial Services |
Kodiak Sciences, Inc.
Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
Kronos Bio, Inc.
Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Brii Biosciences Ltd. (China)
Brii Biosciences Ltd. (China) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national